Stay updated with breaking news from Reverse Bioengineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Item 1.02 Termination of a Material Definitive Agreement. On November 27, 2023, Juvenescence Limited notified AgeX that Juvenescence is terminating a March 29, 20219 the...
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30, 2023.Balance Sheet InformationCash, cash equivalents, an...
AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,... -Today at 04:06 pm- MarketScreener